Guyer William 4
4 · CORCEPT THERAPEUTICS INC · Filed Jan 8, 2026
Insider Transaction Report
Form 4
Guyer William
Chief Development Officer
Transactions
- Exercise/Conversion
Common Stock
2026-01-06$21.65/sh+20,000$433,000→ 21,235 total - Sale
Common Stock
2026-01-06$35.18/sh−20,000$703,656→ 1,235 total - Exercise/Conversion
Stock option (right to buy)
2026-01-06−20,000→ 250,000 totalExercise: $21.65Exp: 2031-09-01→ Common Stock (20,000 underlying)
Footnotes (3)
- [F1]This transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on November 27, 2024 in effect at the time of this transaction.
- [F2]Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $34.96 to $35.50 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
- [F3]Fully exercisable.